[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100602229":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":43,"collaborators":19,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":19,"enrollmentInfo":57,"targetDuration":19,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"University of Sao Paulo General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Group","EXPERIMENTAL","Participants in this arm will take part in one of three phases of the questionnaire validation study:\n\n1. content validation by expert judges,\n2. semantic validation by patients with pulmonary arterial hypertension (PAH),\n3. psychometric validation in a larger sample of up to 200 patients with confirmed PAH.\n\nIn the psychometric phase, participants will complete the final version of the SAVOIR questionnaire. Additional clinical and functional data will be collected from medical records, including:\n\nrisk stratification using the COMPERA 2.0 method,\n\nThese data will be used to explore associations between patient knowledge and clinical\u002Ffunctional outcomes.",[13],"Other: Application of Patient Knowledge Questionnaire on Pulmonary Hypertension",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"Application of Patient Knowledge Questionnaire on Pulmonary Hypertension","Participants will complete one version of the SAVOIR questionnaire, developed to assess patient knowledge about pulmonary arterial hypertension. Depending on the study phase, participants will contribute to content validation (expert judges), semantic validation (patients), or psychometric validation (patients). In the final phase, additional data including risk stratification (COMPERA 2.0) will be collected for correlational analysis.",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Caio Fernandes Principal Investigato, PhD","CONTACT","+55 11 2661 5034","caio.cesar@hc.fm.usp.br",[27],{"facility":28,"status":29,"city":30,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Instituto do Coração (InCor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo","RECRUITING","São Paulo","05403-900","Brazil","BR",{"type":35,"coordinates":36},"Point",[37,38],-46.63611,-23.5475,{"lat":38,"lon":37},[41],{"name":42,"role":23,"phone":24,"phoneExt":19,"email":25},"Caio Fernandes, PhD",{"type":44,"investigatorFullName":45,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Caio Júlio César dos Santos Fernandes","Principal Investigator","100602229","validation-of-a-patient-knowledge-questionnaire-for-pulmonary-hypertension-100602229",false,"NCT07120789","Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension","Content, Semantic, and Psychometric Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension","SAVOIR","Inclusion Criteria:\n\n* Adults aged 18 years or older\n* Confirmed diagnosis of Group 1 Pulmonary Arterial Hypertension (PAH)\n* Ability to read and understand the questionnaire language\n* Provided informed consent to participate in the study\n* For expert judges (content validation phase): professionals with recognized expertise in pulmonary hypertension, with academic or clinical experience in the field\n\nExclusion Criteria:\n\n* Cognitive, visual, or auditory impairments that hinder questionnaire comprehension\n* Refusal to participate or withdrawal of informed consent\n* Inability to complete the questionnaire due to clinical instability","ALL","18 Years",{"count":58,"type":59},215,"ESTIMATED","INTERVENTIONAL",[62],"NA","This methodological study aims to develop and validate a questionnaire named for the Assessment of Patient Knowledge in Pulmonary Arterial Hypertension. The study will be conducted in four phases: (1) questionnaire development based on guidelines and literature; (2) content validation by expert judges; (3) semantic validation with patients; and (4) psychometric testing in a sample of up to 200 patients with confirmed pulmonary arterial hypertension (PAH).\n\nIn addition to validation, the study will collect clinical and functional data from medical records, including risk stratification using the COMPERA 2.0 method The final instrument is expected to support patient education strategies and contribute to improved clinical management of PAH.",[65,66,67],"Pulmonary Arterial Hypertension (PAH)","Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)","Pulmonary Hypertension",[67,69,70,71,72,73,74,75,76],"Patient Knowledge","Questionnaire Validation","Content Validity","Semantic Analysis","Psychometric Validation","Health Education","Patient Education","Chronic Disease","2026-03-07",{"date":79,"type":80},"2026-03-10","ACTUAL",{"date":82,"type":80},"2025-09-01",{"date":84,"type":59},"2026-12",{"name":5,"class":6},1]